Natera, Inc. (NASDAQ:NTRA – Get Rating) – Research analysts at Piper Sandler reduced their Q1 2022 EPS estimates for Natera in a research note issued to investors on Monday, March 21st. Piper Sandler analyst D. Westenberg now forecasts that the medical research company will earn ($1.39) per share for the quarter, down from their previous […]